peter j. howanitz md

30
PETER J. HOWANITZ MD PROFESSOR, VICE CHAIRMAN & CLINICAL LABORATORY DIRECTOR DEPARTMENT OF PATHOLOGY STATE UNIVERSITY OF NEW YORK Downstate Medical Center Brooklyn , NY, USA [email protected] 1

Upload: altessa

Post on 24-Feb-2016

107 views

Category:

Documents


5 download

DESCRIPTION

PETER J. HOWANITZ MD. PROFESSOR, VICE CHAIRMAN & CLINICAL LABORATORY DIRECTOR DEPARTMENT OF PATHOLOGY STATE UNIVERSITY OF NEW YORK Downstate Medical Center Brooklyn , NY, USA [email protected]. INTRODUCTION. Definition & Significance Of Hemolysis Discuss Practice Patterns - PowerPoint PPT Presentation

TRANSCRIPT

Page 1: PETER J. HOWANITZ MD

1

PETER J. HOWANITZ MD

PROFESSOR, VICE CHAIRMAN & CLINICAL LABORATORY DIRECTOR

DEPARTMENT OF PATHOLOGYSTATE UNIVERSITY OF NEW YORK

Downstate Medical Center Brooklyn , NY, USA

[email protected]

Page 2: PETER J. HOWANITZ MD

2

INTRODUCTION• Definition & Significance Of Hemolysis• Discuss Practice Patterns• Determine Causes• Propose Improvements• Conclusions

Page 3: PETER J. HOWANITZ MD

3

Hemolysis is the disruption of the blood cell membrane with the release of the blood cell

contents into the surrounding fluid.

Page 4: PETER J. HOWANITZ MD

4

SOME IN VIVO HEMOLYSIS CAUSES

• Hemolytic Transfusion Rx, Autoimmune Warm Ab• Hereditary Spherocytosis, G6PD Def, Sickle Cell• Hemolytic Transfusion Rx, Autoimmune Warm Ab• Anti-malarials, Aspirin, Chloramphenicol• Malaria, Clostridia, DIC• Burns, Liver & Renal Disease, PNH• March Hemoglobinuria, Prosthetic Heart Valves

Page 5: PETER J. HOWANITZ MD

5

PHLEBOTOMY RELATED CAUSES

Catheter IV CollectionDrawn From Hematoma

Capillary CollectionPhlebotomy EquipmentPhlebotomy Antiseptic

Tourniquet Time

Lippi….Green et al. Clin Chem Lab Med 2009;47:143

Location of StickNo Mixing In Tube

Vigorous Mixing In TubeTraumatic Draw

Tube Under FillingSyringe Transfer

Page 6: PETER J. HOWANITZ MD

6

PRACTICE PATTERNS OF HEMOLYSIS

Page 7: PETER J. HOWANITZ MD

7

CAP QUALITY PRACTICES COMMITTEE STUDY

Q-Probes FormatCAP Chemistry Resource Committee Assistance

7 CAP Chemistry Survey Participants On-Line Questionnaire

28 Multiple Choice Questions7 “Other, Please List” Questions

846 Participants

Page 8: PETER J. HOWANITZ MD

8

0%

5%

10%

15%

20%

25%

30%

35%

40%36% 35%

15%

4%1%

9%

LABORATORY OVERALL HEMOLYSIS RATE (%)

LABORATORY CATEGORY BASED ON HEMOLYSIS RATE

Page 9: PETER J. HOWANITZ MD

9

PROCEDURES USED FOR HEMOLYSIS ID

Parameter % Yes % No % Unsure

Hemolysis visually graded compared to a picture 40 57 3

Visual grading evaluated by competency assessment 18 73 9

Manual procedures identify hemolysis in difficult cases 8 88 4

Able to send automated hemolysis flags to med record 36 50 14

Used automated result verification primary chem analyzer 32 66 2

Same hemolysis scale all analytes primary chem analyzer 81 14 5

Same hemolysis scale primary chem & IA analyzer 70 23 8

Same hemolysis scale primary & backup chem analyzer 74 19 7

Systematically/regularly monitors hemolyzed specimens 47 46 7

Page 10: PETER J. HOWANITZ MD

10

HEMOLYSIS SCALES USED 710 LABS

Page 11: PETER J. HOWANITZ MD

11

HEMOLYSIS REJECTION PRACTICES

Page 12: PETER J. HOWANITZ MD

12

21/69 MOST COMMONLY USED HEMOLYSIS DESCRIPTIVE TERMS

Page 13: PETER J. HOWANITZ MD

13

USE OF 20 CUTOFF HEMOLYSIS TERMS

Page 14: PETER J. HOWANITZ MD

14

ANALYTE SPECIFIC HEMOLYSIS POLICIES

Page 15: PETER J. HOWANITZ MD

15

ATTEMPTED TO VALIDATE HEMOLYSIS FOR ANALYTES

Any

Potassium

Glucose

LD

0% 5% 10% 15% 20% 25% 30% 35%

30%

29%

24%

23%

Page 16: PETER J. HOWANITZ MD

16

CORRECTIVE ACTION DURING PAST YEAR

Page 17: PETER J. HOWANITZ MD

17

LACK OF SUCCESS IN HEMOLYSIS REDUCTION (N=567)

Page 18: PETER J. HOWANITZ MD

18

PHLEBOTOMY RELATED CAUSES

Catheter IV CollectionDrawn From Hematoma

Capillary CollectionPhlebotomy EquipmentPhlebotomy Antiseptic

Tourniquet Time

Lippi et al. Clin Chem Lab Med 2009;47:143

Location of StickNo Mixing In Tube

Vigorous Mixing In TubeTraumatic Draw

Tube Under FillingSyringe Transfer

Page 19: PETER J. HOWANITZ MD

19

WHOLE BLOOD HEMOLYSIS DETECTION

Not Determined

After analyses stored, visually inspected

After analyses centrifuged, visually inspected

K+ elevated,other tubes evaluated

K+ elevated, centrifuged, visually inspected

0% 10% 20% 30% 40% 50% 60%

56%

10%

21%

3%

3%

Page 20: PETER J. HOWANITZ MD

20

CASE REPORTIsmail et al BMJ 330:949,2005

40 Year Old Woman Admitted –Dx SLE5 Days Vomiting, Diarrhea, Weakness

Hb 8.9 g/dl, WBC 6.1 X109 BUN 87 mg/dl Creatinine 4.8 mg/dl

Blood Smear –Diffuse Fragmented Cells Consistent With Microhemangiopathic Hemolytic Anemia

Potassium Cancelled-Hemolyzed

Peter Howanitz
Page 21: PETER J. HOWANITZ MD

21

CASE REPORT CONTINUEDDx-Hemolytic Uremic Syndrome &

Acute Renal Failure Treated Aggressively, & Planned To

Transfer To Dialysis Next DayCardiac Arrest & Died

POST MORTEM ? KIf Known, Immediate Dialysis?

Page 22: PETER J. HOWANITZ MD

22

RECENT INSTRUMENTATION ADVANCES

• Measure Hemolysis• Download Hemolysis To LIS• Provide Extensive Hemolysis Evaluations• Allow Unique Hemolysis Flag By Analyte• Hemolysis Measurements FDA Approved

Page 23: PETER J. HOWANITZ MD

23

COST OF HEMOLYSIS• $203,037 /Yr• Reduced Hemolysis 19.8% To 4.9%• Singapore General Hospital ED• 200 ‘Lyes & Bun/Day• $18.67/Test

Ong et al Am J Med 2009: 122:1054

Page 24: PETER J. HOWANITZ MD

24

COST OF HEMOLYSIS• ICU/DAY•Hospital Charge/Day

Page 25: PETER J. HOWANITZ MD

25

SAME HEMOLYSIS FLAGS AS LIPEMIA OR ICTERUS

LD Glucose Potassium Other0%

10%

20%

30%

40%

50%

60%

70%

53%58%

61%

37%

54% 55%

64%

36%

Lipemia Icterus

Page 26: PETER J. HOWANITZ MD

26

AIDS FOR IMPROVEMENT

Page 27: PETER J. HOWANITZ MD

27

VALIDITY OF DATA ON CAUSES

• Many Studies By Nursing Personnel• Difficulty In Controlling Variables• Unaware Lab vs Nursing Phlebotomists• Some Data Conflicting• Need For Published Studies

Page 28: PETER J. HOWANITZ MD

28

VENIPUNCTURE VERSUS IV CATHETER

Lowe et al. J Emerg Nurs 2008, 34: 26-32

Page 29: PETER J. HOWANITZ MD

29

FIVE IMPROVEMENT SUGGESTIONS

Do Not Reject Hemolyzed SpecimensDevelop Interdepartmental Team(s)

Choose Instruments That Quantitate HemolysisMonitor & Share Successes With Administration

Select Aids For Improvement

Page 30: PETER J. HOWANITZ MD

30

CONCLUSIONS

• Definition & Significance Of Hemolysis• Discussed Clinical Laboratory Practice

Patterns• Established Causes• Provided Suggestions For Improvements